Bioneer

Bioneer A/S is an established Danish specialty CRO and CDMO providing customized research services for early-stage drug discovery and development. With nearly 40 years of experience, it partners with global biotech/pharma companies to advance small molecules, peptides, biologics/recombinant proteins from concept through preclinical stages. The company offers expertise in gene editing/cell line engineering, molecular histology/detection assays, formulation strategies for peptides/small molecules/biologics, and advanced analytical services. Bioneer's business model centers around contract research/service provision rather than internal clinical programs or proprietary therapeutics.